Navigation Links
Halozyme Therapeutics Reports 2008 First Quarter Financial Results
Date:5/8/2008

sales 37,190 76,228

Research and development 8,444,191 2,829,364

Selling, general and administrative 4,157,603 1,985,034

Total Operating Expenses 12,638,984 4,890,626

LOSS FROM OPERATIONS (10,833,466) (4,080,411)

Interest income 879,469 723,107

NET LOSS $(9,953,997) $(3,357,304)

Basic and diluted net loss per share $(0.13) $(0.05)

Shares used in computing net loss per share,

basic and diluted 78,300,319 69,984,931

HALOZYME THERAPEUTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

AS OF MARCH 31, 2008 AND DECEMBER 31, 2007

March 31, December 31,

2008 2007

(unaudited)

ASSETS:

Cash and cash equivalents $92,558,408 $97,679,085

Accounts receivable 1,130,384 779,825

Inventory 679,083 703,468

Prepaid expenses and other assets 2,252,861 2,014,680

Total current assets 96,620,736 101,177,058

Property and equipment, net 2,251,099 2,283,316

Total Assets $98,871,835 $103,460,374

LIABILITIES AND STOCKHOLDERS' EQUITY:

Accounts payable $3,398,587 $3,055,637

Accrued expenses 2,942,071 2,502,259

Deferred revenue 3,261,983 3,306,225

Total current
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
2. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
3. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
4. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
5. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
6. Halozyme Therapeutics Amends Stockholder Rights Plan
7. Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
8. Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference
9. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
10. Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBCs 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
11. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... (PRWEB) May 21, 2013 Through science ... and funds for lab equipment, 25 organizations will continue ... importance of optics and photonics in daily life with ... , The organizations, located in 10 countries, are the ... be awarded by SPIE, the international society for ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 ... services company for clinical trials, announced today it ... Solutions, LLC. Clinverse’s ClinPay® FLS eClinical commerce ... payment process. SpendMD ™, Aggregate Spend ... solution for tracking and reporting transfer of value ...
(Date:5/21/2013)... Emerson Resources Inc. , a premier ... the Company’s Chief Executive Officer and Chairman of the ... of service. As part of Emerson Resources’ planned leadership ... named as Dr. Signorino’s successor. , Dr. Signorino ... made a significant contribution to the field during his ...
(Date:5/21/2013)... Revolutionary Science, the manufacturer of the IncuCount ... they have expanded their colony counter product line to ... and ImpressCount. These affordable colony counters that range ... microbiology and pharmaceutical manufacturing. , The previously released IncuCount ... white enclosure with jet black accents represent the updated ...
Breaking Biology Technology:Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2
... 23, 2011 BioDrain Medical, Inc. (OTC Bulletin Board: ... Streamway® System for automated surgical fluid disposal, announced today ... Number 2,495,747 – for the Company,s Streamway System "for ... workers." The patent was granted to the Company in ...
... , MADISON In the computer displays of medical ... already found a major role. But a discovery reported ... of liquid crystal, which have been found to change ... presence of very low concentrations of a particular bacterial ...
... 2011 Today, the United States District Court for ... plaintiffs Cephalon, Inc. (NASDAQ: CEPH ), and ... Mylan Pharmaceuticals Inc., and Mylan Inc., from manufacturing, using, ... capsules, a generic version of Cephalon,s branded product AMRIX®. ...
Cached Biology Technology:BioDrain Medical, Inc. Granted Canadian Patent for its Streamway® Surgical Fluid Management System 2BioDrain Medical, Inc. Granted Canadian Patent for its Streamway® Surgical Fluid Management System 3Liquid crystal droplets discovered to be exquisitely sensitive to an important bacterial lipid 2Liquid crystal droplets discovered to be exquisitely sensitive to an important bacterial lipid 3Cephalon Granted Temporary Restraining Order in AMRIX® Patent Litigation 2Cephalon Granted Temporary Restraining Order in AMRIX® Patent Litigation 3
(Date:5/21/2013)... a class of pharmaceuticals can both prevent and treat ... as "TSPO ligands," are currently used for certain types ... TSPO ligand in young adult mice when pathology was ... pathology was quite severe," said lead researcher Christian Pike ... reduced measures of pathology and improved behavior at both ...
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
(Date:5/21/2013)... scientists have charted the path of insulin action in ... a comprehensive blueprint for understanding what goes wrong in ... Humphrey and Professor David James from Sydney,s Garvan Institute ... online edition of the prestigious journal Cell Metabolism ... plays a very important role in the body because ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
... six thousand years in estuary sedimentation records to look ... published in Global Change Biology , show an ... 60 years. This shift could diminish the ability of ... climate change. According to Dr. Peter Macreadie, University ...
... to understand the effect of ageing on the immune ... Biological Sciences Research Council (BBSRC) announced investment in a ... be led by researchers from the Babraham Institute with ... Laboratory of Molecular Biology. The team hopes to illuminate ...
... springtime but, viewed under the microscope, a pollen grain ... pollen are part of an exhibition at CSIRO Discovery ... The exhibition ,Pollen Under the Microscope, celebrates the ... and speed up our understanding of nature. It ...
Cached Biology News:New research aims to shed light on how aging affects immunity 2New research aims to shed light on how aging affects immunity 3Pollen research not be sniffed at 2
Form: Ready to use Applications: ELISA...
RABBIT ANTI HALOPERIDOL...
Form: Ready to use Applications: ELISA...
Form: Ready to use Applications: Western Blot, ELISA...
Biology Products: